Molecular basis of crosstalk between oncogenic Ras and the master regulator of hematopoiesis GATA-2

EMBO Reports

Volumn 15, Issue 9, 2014, Pages 938-947

  Katsumura, Koichi R ^a   Yang, Chenxi ^b   Boyer, Meghan E ^a   Li, Lingjun ^b   Bresnick, Emery H ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

GATA factor; GATA 2; p38; Ras; transcription

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR GATA 2; CHROMATIN; GATA2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL LYSATE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DELETION MUTANT; DEPHOSPHORYLATION; DNA BINDING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME PHOSPHORYLATION; GENE ACTIVATION; GENE CONTROL; HEMATOPOIESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE RAS; POINT MUTATION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TRANSACTIVATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING; WILD TYPE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA; MUTATION; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PHOSPHORYLATION; PROMOTER REGION; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMATIN; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, RAS; HEMATOPOIESIS; HUMANS; LEUKEMIA; MUTATION; MYELODYSPLASTIC SYNDROMES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC;

EID: 84906858680     PISSN: 1469221X     EISSN: 14693178     Source Type: Journal    
DOI: 10.15252/embr.201438808     Document Type: Article

References (49)

1. Weiss MJ, Orkin SH, (1995) GATA transcription factors: key regulators of hematopoiesis. Exp Hematol 23: 99-107
2. Charron F, Nemer M, (1999) GATA transcription factors and cardiac development. Semin Cell Dev Biol 10: 85-91 (Pubitemid 129505541)
3. Viger RS, Guittot SM, Anttonen M, Wilson DB, Heikinheimo M, (2008) Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol 22: 781-798 (Pubitemid 351485626)
4. Bresnick EH, Katsumura KR, Lee HY, Johnson KD, Perkins AS, (2012) Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies. Nucleic Acids Res 40: 5819-5831
5. Crispino JD, (2005) GATA-1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 16: 137-147
6. Orkin SH, (1995) Hematopoiesis: how does it happen? Curr Opin Cell Biol 7: 870-877
7. Gao X, Johnson KD, Chang YI, Boyer ME, Dewey CN, Zhang J, Bresnick EH, (2013) Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J Exp Med 210: 2833-2842
8. Johnson KD, Hsu AP, Ryu MJ, Wang J, Gao X, Boyer ME, Liu Y, Lee Y, Calvo KR, Keles S, et al, (2012) Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity. J Clin Invest 122: 3692-3704
9. de Pater E, Kaimakis P, Vink CS, Yokomizo T, Yamada-Inagawa T, van der Linden R, Kartalael PS, Camper SA, Speck N, Dzierzak E, et al, (2013) Gata2 is required for HSC generation and survival. J Exp Med 210: 2843-2850
10. Lim KC, Hosoya T, Brandt W, Ku CJ, Hosoya-Ohmura S, Camper SA, Yamamoto M, Engel JD, (2012) Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. J Clin Invest 122: 3705-3717
11. Ling KW, Ottersbach K, van Hamburg JP, Oziemlak A, Tsai FY, Orkin SH, Ploemacher R, Hendriks RW, Dzierzak E, (2004) GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med 200: 871-882 (Pubitemid 39362923)
12. Rodrigues NP, Janzen V, Forkert R, Dombkowski DM, Boyd AS, Orkin SH, Enver T, Vyas P, Scadden DT, (2005) Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood 106: 477-484 (Pubitemid 40981241)
13. Persons DA, Allay JA, Allay ER, Ashmun RA, Orlic D, Jane SM, Cunningham JM, Nienhuis AW, (1999) Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. Blood 93: 488-499 (Pubitemid 29035730)
14. Tipping AJ, Pina C, Castor A, Hong D, Rodrigues NP, Lazzari L, May GE, Jacobsen SE, Enver T, (2009) High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood 113: 2661-2672
15. Vicente C, Vazquez I, Conchillo A, Garcia-Sanchez MA, Marcotegui N, Fuster O, Gonzalez M, Calasanz MJ, Lahortiga I, Odero MD, et al, (2012) Overexpression of GATA2 predicts an adverse prognosis for patients with acute myeloid leukemia and it is associated with distinct molecular abnormalities. Leukemia 26: 550-554
16. Luesink M, Hollink IH, van der Velden VH, Knops RH, Boezeman JB, de Haas V, Trka J, Baruchel A, Reinhardt D, van der Reijden BA, et al, (2012) High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood 120: 2064-2075
17. Hahn CN, Chong CE, Carmichael CL, Wilkins EJ, Brautigan PJ, Li XC, Babic M, Lin M, Carmagnac A, Lee YK, et al, (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43: 1012-1017
18. Hsu AP, Sampalo EP, Khan J, Calvo KR, Lemieux JE, Patel SY, Frucht DM, Vinh DC, Auth RD, Freeman AF, et al, (2011) Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118: 2653-2655
19. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, et al, (2011) Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43: 929-931
20. Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M, Lakey JH, Rahman T, Wang XN, McGovern N, et al, (2011) Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118: 2656-2658
21. Hsu AP, Johnson KD, Falcone EL, Sanalkumar R, Sanchez L, Hickstein DD, Cuellar-Rodriguez J, Lemieux JE, Zerbe CS, Bresnick EH, et al, (2013) GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. Blood 121: 3830-3837, S3831-3837
22. Porcher C, Liao EC, Fujiwara Y, Zon LI, Orkin SH, (1999) Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development 126: 4603-4615
23. Liu N, Barbosa AC, Chapman SL, Bezprozvannaya S, Qi X, Richardson JA, Yanagisawa H, Olson EN, (2009) DNA binding-dependent and -independent functions of the Hand2 transcription factor during mouse embryogenesis. Development 136: 933-942
24. Pal S, Cantor AB, Johnson KD, Moran T, Boyer ME, Orkin SH, Bresnick EH, (2004) Coregulator-dependent facilitation of chromatin occupancy by GATA-1. Proc Natl Acad Sci U S A 101: 980-985 (Pubitemid 38160570)
25. Lamonica JM, Vakoc CR, Blobel GA, (2006) Acetylation of GATA-1 is required for chromatin occupancy. Blood 108: 3736-3738 (Pubitemid 44864552)
26. Weiss MJ, Yu C, Orkin SH, (1997) Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol 17: 1642-1651 (Pubitemid 27097393)
27. Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, Kang YA, Choi K, Farnham PJ, Bresnick EH, (2009) Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol Cell 36: 667-681
28. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH, (2003) GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc Natl Acad Sci U S A 100: 8811-8816 (Pubitemid 36899180)
29. Grass JA, Jing H, Kim S-I, Martowicz ML, Pal S, Blobel GA, Bresnick EH, (2006) Distinct functions of dispersed GATA factor complexes at an endogenous gene locus. Mol Cell Biol 26: 7056-7067 (Pubitemid 44477685)
30. Pal S, Nemeth MJ, Bodine D, Miller JL, Svaren J, Thein SL, Lowry PJ, Bresnick EH, (2004) Neurokinin-B transcription in erythroid cells: direct activation by the hematopoietic transcription factor GATA-1. J Biol Chem 279: 31348-31356 (Pubitemid 39037801)
31. Moignard V, Macaulay IC, Swiers G, Buettner F, Schutte J, Calero-Nieto FJ, Kinston S, Joshi A, Hannah R, Theis FJ, et al, (2013) Characterization of transcriptional networks in blood stem and progenitor cells using high-throughput single-cell gene expression analysis. Nat Cell Biol 15: 363-372
32. Lancrin C, Mazan M, Stefanska M, Patel R, Lichtinger M, Costa G, Vargel O, Wilson NK, Moroy T, Bonifer C, et al, (2012) GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment. Blood 120: 314-322
33. Linnemann AK, O'Geen H, Keles S, Farnham PJ, Bresnick EH, (2011) Genetic framework for GATA factor function in vascular biology. Proc Natl Acad Sci U S A 108: 13641-13646
34. Beck D, Thoms JA, Perera D, Schutte J, Unnikrishnan A, Knezevic K, Kinston SJ, Wilson NK, O'Brien TA, Gottgens B, et al, (2013) Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood 122: e12-e22
35. Kumar MS, Hancock DC, Molina-Arcas M, Steckel M, East P, Diefenbacher M, Armenteros-Monterroso E, Lassailly F, Matthews N, Nye E, et al, (2012) The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer. Cell 149: 642-655
36. Steckel M, Molina-Arcas M, Weigelt B, Marani M, Warne PH, Kuznetsov H, Kelly G, Saunders B, Howell M, Downward J, et al, (2012) Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Res 22: 1227-1245
37. Koga S, Yamaguchi N, Abe T, Minegishi M, Tsuchiya S, Yamamoto M, Minegishi N, (2007) Cell-cycle-dependent oscillation of GATA2 expression in hematopoietic cells. Blood 109: 4200-4208 (Pubitemid 46743384)
38. Menghini R, Marchetti V, Cardellini M, Hribal ML, Mauriello A, Lauro D, Sbraccia P, Lauro R, Federici M, (2005) Phosphorylation of GATA2 by Akt increases adipose tissue differentiation and reduces adipose tissue-related inflammation: a novel pathway linking obesity to atherosclerosis. Circulation 111: 1946-1953 (Pubitemid 40570214)
39. Towatari M, May GE, Marais R, Perkins GR, Marshall CJ, Cowley S, Enver T, (1995) Regulation of GATA-2 phosphorylation by mitogen-activated protein kinase and interleukin-3. J Biol Chem 270: 4101-4107
40. Maneechotesuwan K, Xin Y, Ito K, Jazrawi E, Lee KY, Usmani OS, Barnes PJ, Adcock IM, (2007) Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 178: 2491-2498 (Pubitemid 46233450)
41. Frelin C, Herrington R, Janmohamed S, Barbara M, Tran G, Paige CJ, Benveniste P, Zuniga-Pflucker JC, Souabni A, Busslinger M, et al, (2013) GATA-3 regulates the self-renewal of long-term hematopoietic stem cells. Nat Immunol 14: 1037-1044
42. Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, Ohmura M, Naka K, Hosokawa K, Ikeda Y, et al, (2006) Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 12: 446-451
43. Qian H, Buza-Vidas N, Hyland CD, Jensen CT, Antonchuk J, Mansson R, Thoren LA, Ekblom M, Alexander WS, Jacobsen SE, (2007) Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1: 671-684 (Pubitemid 350215331)
44. Navas TA, Mohindru M, Estes M, Ma JY, Sokol L, Pahanish P, Parmar S, Haghnazari E, Zhou L, Collins R, et al, (2006) Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood 108: 4170-4177 (Pubitemid 44913289)
45. Yamazaki H, Suzuki M, Otsuki A, Shimizu R, Bresnick EH, Engel JD, Yamamoto M, (2014) A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression. Cancer Cell 25: 415-427
46. Groschel S, Sanders MA, Hoogenboezem R, de Wit E, Bouwman BA, Erpelinck C, van der Velden VH, Havermans M, Avellino R, van Lom K, et al, (2014) A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia. Cell 157: 369-381
47. Im H, Grass JA, Johnson KD, Boyer ME, Wu J, Bresnick EH, (2004) Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol Biol 284: 129-146
48. Taus T, Kocher T, Pichler P, Paschke C, Schmidt A, Henrich C, Mechtler K, (2011) Universal and confident phosphorylation site localization using phosphoRS. J Proteome Res 10: 5354-5362
49. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ, (2006) Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics 5: 144-156 (Pubitemid 43169347)